Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process
(SUVENPHAR)
XNSE:SUVENPHAR, XBOM:SUVENPHAR
Suven Pharmaceuticals Ltd Q4FY24; 57% fall in Profits
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process
Suven Pharmaceuticals Ltd Q2FY24; 11% rise in Profits
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial
Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial
Suven Pharmaceuticals Ltd Q4FY23 results out, net profit grows by 35%
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL
Suven pharmaceuticals Q3FY23 net profit drops by 33 percent
The company has reported total income of INR 366.78 crores during the period ended December 31, 2022 as compared to INR 456.27